IGF-1 LR3 — SEO Product Content

SEO Title

IGF-1 LR3 Peptide | Long R3 IGF-1 Research Peptide

SEO Meta Description

IGF-1 LR3 research peptide for studies of IGF-1 receptor signaling, cellular growth, protein metabolism, IGF-binding proteins, tissue biology and bioenergetics.

Suggested URL Slug

/product/igf-1-lr3/

SEO Product Description

IGF-1 LR3 Research Peptide

IGF-1 LR3, also known as Long R3 IGF-1 or Long Arg3 IGF-1, is a modified analogue of insulin-like growth factor-1 (IGF-1) investigated in research involving growth-factor signaling, cellular proliferation, protein metabolism, tissue biology and cellular energy regulation.

The Long R3 analogue was designed with structural modifications that substantially reduce its affinity for IGF-binding proteins (IGFBPs). This makes it a useful experimental tool for studying IGF signaling under conditions where binding-protein interactions differ from those of native IGF-1. Experimental studies have demonstrated biological activity of Long R3 IGF-1 in animal models.

Pure Axis Peptides offers IGF-1 LR3 as a research-use peptide for qualified laboratory and scientific investigations.

What Is IGF-1 LR3?

IGF-1 LR3 is a modified form of insulin-like growth factor-1.

The name “LR3” refers to the Long R3 analogue designation. Compared with native IGF-1, the modified molecule has altered structural characteristics that affect its interactions with IGF-binding proteins.

This makes IGF-1 LR3 particularly interesting for experimental research into:

• IGF-1 receptor signaling
• IGF-binding proteins
• Growth-factor biology
• Cellular proliferation
• Protein metabolism
• Tissue growth
• Cellular bioenergetics
• Metabolic signaling

IGF-1 LR3 and IGF-1 Receptor Signaling

The primary biological receptor for IGF-1 is the type 1 insulin-like growth factor receptor (IGF-1R).

IGF-1R is a receptor tyrosine kinase that regulates cellular growth, proliferation, differentiation and metabolism. Structural research has demonstrated how IGF-1 interacts with IGF-1R to activate the receptor.

This creates an important experimental signaling pathway:

IGF-1 LR3 → IGF-1R → intracellular kinase signaling → cellular response

Research involving IGF-1R can examine:

• Receptor activation
• Tyrosine phosphorylation
• PI3K/Akt signaling
• MAPK/ERK signaling
• Cellular proliferation
• Protein synthesis
• Metabolic signaling

IGF-1 LR3 and IGF-Binding Proteins

A major reason Long R3 IGF-1 is used in research is its altered interaction with IGF-binding proteins (IGFBPs).

Native IGF-1 circulates in association with several IGFBPs that influence its distribution, stability and biological availability.

Experimental work with LR3IGF-I has specifically examined its much-reduced affinity for IGF-binding proteins compared with native IGF-I.

This makes IGF-1 LR3 a useful experimental model for studying the distinction between:

IGF receptor signaling

and

IGFBP-mediated regulation of IGF bioavailability

IGF-1 LR3 and Cellular Growth Research

IGF-1 is an important growth factor involved in cellular growth and differentiation.

Activation of IGF-1R can influence intracellular signaling pathways that regulate:

• Cell growth
• Cell survival
• Protein synthesis
• Cellular differentiation
• Metabolism
• Tissue development

Because LR3IGF-I can interact with the IGF system while displaying altered IGFBP binding, it provides researchers with a modified experimental ligand for investigating growth-factor biology.

IGF-1 LR3 and PI3K/Akt Signaling

The PI3K/Akt pathway is one of the major intracellular signaling systems associated with IGF-1 receptor activation.

IGF-1R signaling can influence Akt-dependent pathways involved in:

• Protein metabolism
• Cell survival
• Glucose handling
• Cellular growth
• Metabolic regulation

This makes IGF-1 LR3 relevant to research investigating growth-factor-mediated metabolic signaling.

IGF-1 LR3 and MAPK/ERK Signaling

IGF-1R can also activate MAPK/ERK signaling, a pathway involved in cellular proliferation, differentiation and gene-expression regulation.

Researchers can use IGF-related experimental systems to investigate the balance between:

IGF-1R → PI3K/Akt

and

IGF-1R → MAPK/ERK

These pathways help explain why IGF signaling can influence both metabolic and cellular-growth processes.

IGF-1 LR3 and Protein Metabolism

IGF-1 is strongly associated with regulation of protein metabolism.

Experimental studies have investigated Long R3 IGF-1 in animal models undergoing different nutritional and metabolic states.

In a study involving feed-restricted beef heifers, Long R3 IGF-1 administration was associated with changes in whole-body and skeletal-muscle protein metabolism and altered circulating amino-acid concentrations.

These findings provide a research basis for investigating:

• Protein turnover
• Amino-acid metabolism
• Skeletal-muscle protein metabolism
• Nitrogen balance
• Growth-factor signaling

They should not be interpreted as evidence of a human muscle-building effect.

IGF-1 LR3 and Skeletal-Muscle Research

Skeletal muscle is highly responsive to growth-factor signaling.

IGF pathways are involved in experimental studies of:

• Muscle-cell growth
• Protein synthesis
• Satellite-cell biology
• Cellular differentiation
• Muscle metabolism
• Tissue remodeling

Long R3 IGF-1 has therefore been used in preclinical research examining the effects of sustained IGF signaling on tissue and protein metabolism.

Importantly, experimental animal findings do not establish equivalent effects or safety in healthy humans.

IGF-1 LR3 and Tissue Research

IGF signaling participates in the regulation of many tissues.

Experimental research has investigated Long R3 IGF-1 in relation to changes in tissue growth and organ biology.

In a guinea-pig study, seven days of Long R3 IGF-I infusion increased the fractional weight of several organs, including the adrenals, gut, kidneys and spleen, although overall body growth was not stimulated.

This demonstrates why tissue-specific effects should be evaluated carefully rather than reducing IGF-1 LR3 research to generalized “growth.”

IGF-1 LR3 and Metabolic Research

IGF-1 signaling intersects with multiple metabolic pathways.

Research involving IGF-1 and its analogues can investigate:

• Glucose metabolism
• Amino-acid metabolism
• Protein turnover
• Cellular energy
• Growth-factor signaling
• Insulin/IGF pathway interactions

IGF-1R belongs to the same broader receptor family as the insulin receptor, making comparative receptor research particularly valuable.

IGF-1 LR3 and Insulin Signaling

IGF-1R and the insulin receptor are structurally related receptor tyrosine kinases.

Although they have different ligand preferences and physiological roles, their downstream signaling pathways overlap in important ways.

This makes IGF-1 LR3 relevant to research examining:

• Insulin/IGF receptor biology
• Receptor specificity
• PI3K/Akt signaling
• Glucose metabolism
• Growth signaling
• Metabolic regulation

Because IGF-1 can influence glucose homeostasis, metabolic studies involving IGF-1 analogues should carefully monitor glucose-related endpoints in experimental systems.

IGF-1 LR3 and Neurobiology

IGF signaling is also important in the nervous system.

Research into IGF-1 and IGF-1R has investigated:

• Neuronal survival
• Neural development
• Neuroplasticity
• Brain metabolism
• Cellular stress
• Neurodegenerative mechanisms

Long R3 IGF-1 has been investigated experimentally in neurological models.

A recent mouse study examining intranasal Long R3 IGF-1 in an Alzheimer’s disease model reported changes in amyloid-plaque remodeling but did not preserve cognitive function.

This is an important example of why individual experimental findings should not be translated directly into claims of cognitive enhancement or Alzheimer’s treatment.

IGF-1 LR3 and Cellular Bioenergetics

Growth-factor signaling and cellular energy metabolism are closely interconnected.

IGF-1R activation can influence pathways involved in:

• Glucose utilization
• Protein metabolism
• Mitochondrial activity
• Cellular survival
• Energy availability

This creates a natural research connection between IGF-1 LR3 and broader cellular-bioenergetics research.

IGF-1 LR3 and Growth-Factor Research

IGF-1 LR3 belongs to a broader family of growth factors and growth-factor analogues.

Researchers can use it to investigate differences between:

• Native IGF-1
• Long R3 IGF-1
• IGF-binding protein-associated IGF
• IGF-1R signaling
• Insulin receptor signaling

This makes IGF-1 LR3 particularly useful for mechanistic studies of ligand-receptor interactions.

IGF-1 LR3 Research Applications

IGF-1 LR3 may be relevant to laboratory studies involving:

IGF-1R Research: Investigating insulin-like growth factor receptor activation.

IGFBP Research: Studying the relationship between IGF-1 and IGF-binding proteins.

Growth-Factor Biology: Investigating cellular growth and differentiation.

Protein Metabolism: Studying amino-acid utilization and protein turnover.

Muscle Biology: Investigating skeletal-muscle cellular responses to IGF signaling.

Metabolic Research: Studying glucose and energy metabolism.

Signal Transduction: Examining PI3K/Akt and MAPK/ERK pathways.

Neuroscience: Investigating IGF-related neuronal signaling.

Cellular Bioenergetics: Studying relationships between growth-factor signaling and cellular energy.

Receptor Pharmacology: Comparing IGF-1R and insulin-receptor signaling.

IGF-1 LR3 vs. Native IGF-1

Native IGF-1 and IGF-1 LR3 are related but should not be treated as identical research materials.

Native IGF-1

• Endogenous human growth factor
• Strongly regulated by IGF-binding proteins
• Important physiological component of the GH/IGF axis
• Interacts with IGF-1R

IGF-1 LR3

• Modified IGF-1 analogue
• Altered structure relative to native IGF-1
• Reduced affinity for IGF-binding proteins
• Used experimentally to investigate altered IGF bioavailability and signaling

Experimental results obtained with LR3 should therefore not automatically be generalized to native IGF-1.

IGF-1 LR3 vs. IGF-1 DES

IGF-1 DES and IGF-1 LR3 are distinct IGF-1 analogues.

IGF-1 DES is a truncated analogue, while Long R3 IGF-1 incorporates structural modifications designed to alter its interaction with IGF-binding proteins.

These differences make them useful for comparative studies involving:

• Receptor activity
• Binding-protein interactions
• Peptide structure
• Cellular signaling
• Exposure characteristics

If both products are available in the Pure Axis catalog, they should be strongly cross-linked.

IGF-1 LR3 vs. MGF / PEG-MGF

IGF-1 LR3 and MGF-related peptides belong to the broader research field of growth-factor and muscle biology, but they are not interchangeable.

IGF-1 LR3 is a modified systemic IGF-1 analogue.

MGF-related peptides are associated with alternatively spliced IGF-1 transcripts and distinct biological contexts.

Researchers should maintain separate product pages and use comparative content to explain their different molecular identities.

Explore PEG-MGF for related growth-factor research.

IGF-1 LR3 Research Material

Researchers should verify the current Pure Axis Peptides product specification, peptide identity, sequence, purity, formulation, storage requirements and batch-specific certificate of analysis (COA) before laboratory use.

Because IGF-1 LR3 is a biologically active growth-factor analogue, experimental handling should follow appropriate laboratory procedures.

Explore Related Research

IGF-1 LR3 fits naturally into a broader growth-factor, muscle-biology and metabolic-research cluster.

Explore PEG-MGF for related IGF/MGF research.

Browse the Peptides collection for additional peptide research materials.

Explore Research Chemicals for additional laboratory materials.

Visit Shop All Products for the complete Pure Axis Peptides catalog.

Research Use Only

IGF-1 LR3 supplied by Pure Axis Peptides is intended strictly for laboratory and scientific research. It is not intended for human consumption, self-administration, diagnosis, treatment, cure, or prevention of any disease or medical condition. IGF-1 LR3 is a biologically active growth-factor analogue, and experimental findings should not be interpreted as establishing safety or efficacy for muscle growth, fat loss, injury recovery, cognitive enhancement or other clinical uses. Researchers should evaluate all materials according to their experimental requirements, product documentation and applicable laboratory procedures.

Internal Linking Recommendations

Primary Internal Links

• PEG-MGF → https://pureaxispeptides.com/product/peg-mgf/
• Peptides → https://pureaxispeptides.com/product-category/peptides/
• Research Chemicals → https://pureaxispeptides.com/product-category/research-chemicals/
• Shop All Products → https://pureaxispeptides.com/shop/

Verify all live WooCommerce URLs before publishing.

Recommended Related-Product Links

If these products exist in the Pure Axis catalog, also link IGF-1 LR3 with:

• IGF-1 DES
• MGF
• PEG-MGF
• CJC-1295
• GHRP-2
• GHRP-6
• Hexarelin
• Other growth-factor or GH-axis research peptides

Recommended Internal-Link Anchors

Use varied contextual anchors such as:

• “IGF-1 research peptide”
• “IGF-1 receptor research”
• “IGF-1R signaling”
• “growth-factor research”
• “IGF-binding protein research”
• “cellular growth research”
• “protein metabolism research”
• “muscle-cell research”
• “PEG-MGF research”
• “GH/IGF-1 axis research”

Recommended Site Architecture

Build a dedicated GH / IGF growth-factor cluster:

IGF-1 LR3
→ IGF-1 receptor
→ IGF-binding proteins
→ Native IGF-1
→ IGF-1 DES
→ MGF / PEG-MGF
→ CJC-1295
→ GHRPs
→ GH/IGF-1 axis
→ Muscle-cell biology
→ Metabolic research

This gives Pure Axis a strong topical structure around the GH/IGF signaling system.

External Scientific References

• PubMed — Long R3 IGF-I and organ-growth research:
  https://pubmed.ncbi.nlm.nih.gov/7561636/ (pubmed.ncbi.nlm.nih.gov)
• PubMed — Long R3 IGF-I and protein metabolism:
  https://pubmed.ncbi.nlm.nih.gov/10370861/ (pubmed.ncbi.nlm.nih.gov)
• PubMed — Structural basis of IGF-1 receptor activation:
  https://pubmed.ncbi.nlm.nih.gov/31594955/ (pubmed.ncbi.nlm.nih.gov)
• PubMed — IGF-1 receptor structure and biology:
  https://pubmed.ncbi.nlm.nih.gov/11376122/ (pubmed.ncbi.nlm.nih.gov)
• PubMed — IGF-1 receptor primary structure:
  https://pubmed.ncbi.nlm.nih.gov/2877871/ (pubmed.ncbi.nlm.nih.gov)
• PubMed — IGF-1 receptor vs. insulin receptor specificity:
  https://pubmed.ncbi.nlm.nih.gov/16894147/ (pubmed.ncbi.nlm.nih.gov)
• PubMed — Long R3 IGF-1 in an Alzheimer’s disease mouse model:
  https://pubmed.ncbi.nlm.nih.gov/39610283/ (pubmed.ncbi.nlm.nih.gov)

Product Tags

IGF-1 LR3, IGF1 LR3, IGF-1 LR3 Peptide, IGF-1 LR3 Research, IGF-1 LR3 Research Peptide, Long R3 IGF-1, Long R3 IGF-I, Long Arg3 IGF-1, LR3 IGF-1, Insulin-Like Growth Factor-1, IGF-1 Peptide, IGF Research, IGF-1 Research, IGF-1R, IGF-1 Receptor, IGF-1R Research, IGF Binding Protein, IGFBP Research, Growth Factor Research, Growth Factor Peptide, Growth Factor Signaling, PI3K Akt Research, MAPK ERK Research, Protein Metabolism Research, Cellular Growth Research, Cell Proliferation Research, Muscle Cell Research, Skeletal Muscle Research, Metabolic Research, Cellular Bioenergetics, GH IGF-1 Axis, Growth Hormone Research, MGF Research, PEG-MGF, Peptide Pharmacology, Research Peptide, Laboratory Research